Global Information
회사소개 | 문의 | 비교리스트

세계의 완전 치환형 인공심장 시장 : 의료기기 파이프라인 평가(2020년)

Total Artificial Heart - Medical Devices Pipeline Assessment, 2020

리서치사 GlobalData
발행일 2020년 08월 상품 코드 954324
페이지 정보 영문
가격
US $ 2,500 ₩ 2,954,000 PDF (Single User License)
US $ 5,000 ₩ 5,909,000 PDF (Site License)
US $ 7,500 ₩ 8,863,000 PDF (Global License)


세계의 완전 치환형 인공심장 시장 : 의료기기 파이프라인 평가(2020년) Total Artificial Heart - Medical Devices Pipeline Assessment, 2020
발행일 : 2020년 08월 페이지 정보 : 영문

세계 완전 치환형 인공심장 시장의 주요 파이프라인 제품(의료기기)과 임상시험 진행 상황에 대해 조사했으며, 제품의 기능·특성 비교 분석(임상시험 진행 단계별), 주요 기업의 개요 및 대표적 제품, 최근 시장 동향(실적 보고·자본거래 동향 등) 등의 정보를 정리하여 전해드립니다.

제1장 목차

제2장 서론

  • 완전 치환형 인공심장의 개요

제3장 개발중인 제품

  • 파이프라인 제품 : 임상시험 단계별
  • 파이프라인 제품 : 지역별
  • 파이프라인 제품 : 규제 경로별
  • 파이프라인 제품 : 추정 인증 시기별
  • 현재 진행중인 임상시험

제4장 제4장 임상시험중인 파이프라인 제품 : 기업별

  • 완전 치환형 인공심장 기업 : 임상시험 단계별 파이프라인 제품
  • 완전 치환형 인공심장 : 임상시험 단계별 파이프라인 제품

제5장 완전 치환형 인공심장 시장 : 기업·제품의 개요

  • Abiomed Inc
    • 파이프라인 제품 및 현재 진행중인 임상시험의 개요
  • BiVacor Pty Ltd
  • Carmat SAS
  • Cleveland Clinic Lerner College of Medicine
  • Cleveland Heart Inc
  • Foster-Miller Inc(Inactive)
  • Indian Institute of Technology Kharagpur
  • Lausanne University Hospital
  • OregonHeart Inc(Inactive)
  • ReliantHeart, Inc.
  • Scandinavian Real Heart AB
  • Syncardia Systems LLC
  • TEDA International Cardiovascular Hospital
  • University of Tokyo
  • Yale University

제6장 완전 치환형 인공심장 시장 : 최근 동향

제7장 부록

KSA 20.08.31

List of Tables

List of Tables

  • Table 1: Total Artificial Heart - Pipeline Products by Stage of Development
  • Table 2: Total Artificial Heart - Pipeline Products by Territory
  • Table 3: Total Artificial Heart - Pipeline Products by Regulatory Path
  • Table 4: Total Artificial He

List of Figures

List of Figures

  • Figure 1: Total Artificial Heart - Pipeline Products by Stage of Development
  • Figure 2: Total Artificial Heart - Pipeline Products by Territory
  • Figure 3: Total Artificial Heart - Pipeline Products by Regulatory Path
  • Figure 4: Total Artifici

GlobalData's Medical Devices sector report, "Total Artificial Heart - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Total Artificial Heart pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Total Artificial Heart is a prosthetic device that is implanted into the body to replace the biological heart.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Total Artificial Heart under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Total Artificial Heart and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Total Artificial Heart under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Total Artificial Heart Overview

3 Products under Development

  • 3.1 Total Artificial Heart - Pipeline Products by Stage of Development
  • 3.2 Total Artificial Heart - Pipeline Products by Territory
  • 3.3 Total Artificial Heart - Pipeline Products by Regulatory Path
  • 3.4 Total Artificial Heart - Pipeline Products by Estimated Approval Date
  • 3.5 Total Artificial Heart - Ongoing Clinical Trials

4 Total Artificial Heart - Pipeline Products under Development by Companies

  • 4.1 Total Artificial Heart Companies - Pipeline Products by Stage of Development
  • 4.2 Total Artificial Heart - Pipeline Products by Stage of Development

5 Total Artificial Heart Companies and Product Overview

  • 5.1 Abiomed Inc Company Overview
    • 5.1.1 Abiomed Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 BiVacor Pty Ltd Company Overview
    • 5.2.1 BiVacor Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 Carmat SAS Company Overview
    • 5.3.1 Carmat SAS Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 Cleveland Clinic Lerner College of Medicine Company Overview
    • 5.4.1 Cleveland Clinic Lerner College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Cleveland Heart Inc Company Overview
    • 5.5.1 Cleveland Heart Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 Foster-Miller Inc (Inactive) Company Overview
    • 5.6.1 Foster-Miller Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 Indian Institute of Technology Kharagpur Company Overview
    • 5.7.1 Indian Institute of Technology Kharagpur Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Lausanne University Hospital Company Overview
    • 5.8.1 Lausanne University Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 OregonHeart Inc (Inactive) Company Overview
    • 5.9.1 OregonHeart Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 ReliantHeart, Inc. Company Overview
    • 5.10.1 ReliantHeart, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 Scandinavian Real Heart AB Company Overview
    • 5.11.1 Scandinavian Real Heart AB Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 Syncardia Systems LLC Company Overview
    • 5.12.1 Syncardia Systems LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 TEDA International Cardiovascular Hospital Company Overview
    • 5.13.1 TEDA International Cardiovascular Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 University of Tokyo Company Overview
    • 5.14.1 University of Tokyo Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 Yale University Company Overview
    • 5.15.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview

6 Total Artificial Heart- Recent Developments

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer
Back to Top
전화 문의
F A Q